Faeth Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $146.5M | $7.2M |
| FY2022 | — | $103.4M | $17.8M |
| FY2023 | — | $64.9M | $13.0M |
| FY2024 | — | $38.4M | $10.0M |
| FY2025 | — | $18.6M | $8.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $146.5M | $7.2M |
| FY2022 | — | $103.4M | $17.8M |
| FY2023 | — | $64.9M | $13.0M |
| FY2024 | — | $38.4M | $10.0M |
| FY2025 | — | $18.6M | $8.7M |